Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.

Research headed by teams at the University of Rochester Center for Translational Medicine and the University of Copenhagen describes for the first time how a spreading wave of disruption and the flow ...